Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study

medRxiv(2023)10.1101/2023.10.08.23296717Source: DataRank Database

Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (18)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Xiaosong Wang ORCID,Naomi J. Patel ORCID,Yumeko Kawano ORCID,Emily Kowalski,Claire Cook

Live enrichment

PubMed:37873462 OpenAlex:https://openalex.org/W4387448817

NIAMS NIH HHS

Grant: R01 AR077607

NIAMS NIH HHS

Grant: P30 AR072577

NIAMS NIH HHS

Grant: K23 AR073334

NIAMS NIH HHS

Grant: P30 AR070253

NIAMS NIH HHS

Grant: R01 AR080659

NIAMS NIH HHS

Grant: R03 AR078938

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/10/09/2023.10.08.23296717.full.pdf

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10592996

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/10/09/2023.10.08.23296717.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.10.08.23296717

repositoryhttps://doi.org/10.1101/2023.10.08.23296717

Fields of Study

Rheumatoid Arthritis Research and TherapiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMedicine

Keywords

Rheumatoid arthritisMedicineCoronavirus disease 2019 (COVID-19)CohortSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyVirologyInternal medicineDiseaseInfectious disease (medical specialty)COVID-19epidemiologyimmunosuppressionreinfection

Sustainable Development Goals

SDG 0: Good health and well-being